Search results
Results from the WOW.Com Content Network
Other stool tests involve the detection of antibiotic resistance as to guide appropriate therapy, e.g. Clarithromycin resistance of Helicobacter pylori represents a major challenge in eradication therapy but the responsible bacterial genomic markers can be detected in stool using PCR technology and thus can guide the prescription of the ...
The M2-PK Test is a non-invasive screening method for the early detection of colorectal cancers and polyps which are known to be the precursors of colorectal cancer. The M2-PK Test which is used for stool analysis is available either as fully quantitative ELISA Test or as a rapid test that can be performed by any general practitioner without the need of a laboratory or any additional equipment.
The fecal immunochemical test (FIT) is a diagnostic technique that examines stool samples for traces of non-visible blood, which could potentially indicate conditions including bowel cancer. [1] Symptoms which could be caused by bowel cancer and suggest a FIT include a change in bowel habit, anaemia, unexplained weight loss, and abdominal pain.
In the simplest form of the fecal fat test, a random fecal specimen is submitted to the hospital laboratory and examined under a microscope after staining with a Sudan III or Sudan IV dye ("Sudan staining"). Visible amounts of fat indicate some degree of fat malabsorption.
The digital rectal examination is a relatively simple medical procedure. The patient undresses and is then placed in a position where the anus is accessible (lying on the side, squatting on the examination table, bent over it, or lying down with feet in stirrups).
The test is fast and can be performed in a doctor's office. A patient must not be receiving antibiotics. At least half a milliliter of feces is collected, and a strip of nitrazine paper is dipped in the sample and compared against a color scale.
It was developed in 1954 by Japanese medical laboratory scientist Dr. Katsuya Kato (1912–1991). [6] [7] The technique was modified for use in field studies in 1972 by a Brazilian team of researchers led by Brazilian parasitologist Naftale Katz (b.1940), [8] [9] and this modification was adopted by the WHO as a gold standard for multiple helminth infections.
The stool guaiac test method may be preferable to fecal immunochemical testing (FIT) if there is a clinical concern about possible gastric or proximal upper intestinal bleeding. [37] However, although heme breakdown is less than globin during intestinal transit, false negative results can be seen with the stool guaiac tests due to degradation ...